A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder

Author:

Dodd Seetal1,Malhi Gin S.2,Tiller John3,Schweitzer Isaac3,Hickie Ian4,Khoo Jon Paul5,Bassett Darryl L.6,Lyndon Bill2,Mitchell Philip B.7,Parker Gordon7,Fitzgerald Paul B.8,Udina Marc9,Singh Ajeet1,Moylan Steven10,Giorlando Francesco3,Doughty Carolyn11,Davey Christopher G.12,Theodoros Michael13,Berk Michael14

Affiliation:

1. School of Medicine, Deakin University, Geelong, Victoria, Australia; Department of Psychiatry, University of Melbourne, Victoria, Australia

2. Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

3. Department of Psychiatry, University of Melbourne, Victoria, Australia

4. Brain and Mind Research Institute, University of Sydney, Sydney, New South Wales, Australia

5. Toowong Specialist Clinic, Level 2/54 Jephson St, Toowong, Brisbane, Queensland, Australia

6. School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia; School of Medicine, University of Notre Dame, Western Australia, Australia

7. School of Psychiatry, University of New South Wales, Sydney, Australia; Black Dog Institute, Sydney, Australia

8. Monash Alfred Psychiatry Research Centre, Alfred and Monash University School of Psychology and Psychiatry, Melbourne, Victoria, Australia

9. Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Catalonia, Spain

10. School of Medicine, Deakin University, Geelong, Victoria, Australia

11. Child and Family Specialty Service, Canterbury District Health Board; Department of Public Health and General Practice, University of Otago, Christchurch, New Zealand

12. Orygen Youth Health Research Centre, Parkville, Victoria, Australia

13. Eating Disorders Program, New Farm Clinic, Brisbane, Queensland, Australia

14. School of Medicine, Deakin University, Geelong, Victoria; Department of Psychiatry, University of Melbourne, Victoria; Mental Health Research Institute, Parkville, Victoria; Orygen Youth Health Research Centre, Parkville, Victoria, Australia

Abstract

Objective: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring. Method: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content. Results: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment. Conclusion: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3